mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.5 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.5 |